Sponsor Pipeline

LTZ Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07121946 This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin… Non-Hodgkin Lymphoma Refractory/ Relapsed Recruiting
Disease Areas
Non-Hodgkin Lymphoma (1) DLBCL (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when LTZ Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free